Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

N-acetylcysteine (NAC)

N-Acetyl-L-Cysteine · also known as Acetylcysteine, NAC

NAC supplies cysteine for glutathione (GSH) synthesis, and a randomized human trial showed intracellular GSH being replenished. Its direct free-radical scavenging is limited. Its clinical use as a mucolytic (to thin sputum) is relatively well established.

Typical dose: 600–1800 mg/day, taken in divided doses on an empty stomach or with a light meal
Absorption and forms: Oral bioavailability of NAC is low, about 4–10%. It is deacetylated to free L-cysteine in the small intestinal mucosa and liver, which then feeds GSH synthesis. The effect depends on the tissue and the person’s baseline state, and not every dose raises intracellular GSH by the same amount.

Clinical uses and human evidence

Male fertility (sperm quality)

BeneficialGrade B · Moderate evidence
Studies (1)
  1. Ciftci 2009 · Urology · RCT · n=120 — Effects of N-acetylcysteine on semen parameters and oxidative/antioxidant status

Polycystic ovary syndrome

Mixed resultsGrade B · Moderate evidence
Studies (2)
  1. Fang 2024 · J Ovarian Res · RCT · n=230 — N-acetylcysteine supplementation improves endocrine-metabolism profiles and ovulation induction efficacy in polycystic ovary syndrome
  2. Viña 2025 · Nutrients · meta-analysis · n=2515 — Efficacy of N-Acetylcysteine in Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis

Low mood

Mixed resultsGrade B · Moderate evidence
Studies (1)
  1. Peng 2024 · Gen Hosp Psychiatry · meta-analysis · n=904 — Efficacy of N-acetylcysteine for patients with depression: An updated systematic review and meta-analysis

Fatty liver and liver enzymes

Mixed resultsGrade B · Moderate evidence
Studies (1)
  1. Sinaeinejad 2025 · Addict Health · RCT · n=69 — Efficacy of N-Acetylcysteine on Liver Function and Metabolic Profiles in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Double-Blind, Randomized Controlled Trial

All-cause mortality risk

Mixed resultsGrade B · Moderate evidence
Studies (3)
  1. Rafique 2026 · J Coll Physicians Surg Pak · meta-analysis — N-acetylcysteine as Prophylaxis Against Contrast-Induced Nephropathy: A Meta-Analysis
  2. Guo 2020 · BMJ Open · meta-analysis · n=1710 — Effect of N-acetylcysteine on prevention of contrast-associated acute kidney injury in patients with STEMI undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomised controlled trials
  3. Weisbord 2018 · N Engl J Med · RCT · n=5177 — Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine

Heart attack, stroke and other cardiovascular events

Mixed resultsGrade B · Moderate evidence
Studies (2)
  1. Tepel 2003 · Circulation · RCT · n=134 — The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial
  2. Miner 2004 · Am Heart J · RCT · n=180 — N-acetylcysteine reduces contrast-associated nephropathy but not clinical events during long-term follow-up

Blood sugar and insulin resistance

Mixed resultsGrade C · Preliminary evidence
Studies (1)
  1. Sinaeinejad 2025 · Addict Health · RCT · n=69 — Efficacy of N-Acetylcysteine on Liver Function and Metabolic Profiles in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Double-Blind, Randomized Controlled Trial

Mechanisms of action

Substrate and cofactor supply for glutathione (GSH) synthesis

★★★★★Mechanism evidence: grade A

After deacetylation, NAC provides cysteine and supports GSH synthesis when substrate is limited; this is its defining action. In a randomized, double-blind human trial, GSH was replenished in whole blood and T cells of people with HIV. The effect depends on the tissue and baseline state.

References (1)
  1. De Rosa et al. 2000 · Randomized double-blind trial: oral NAC replenished GSH in whole blood and T cells of people with HIV

Inhibition of NF-κB / AP-1, the master switches of pro-inflammatory transcription

★★☆☆☆Mechanism evidence: grade ASecondary target

Under specific strenuous exercise stress, a randomized double-blind crossover trial in humans found reduced NF-κB phosphorylation in skeletal muscle. This is a secondary effect under that particular stress and does not mean NAC broadly suppresses inflammation.

References (1)
  1. Michailidis et al. 2013 · Randomized double-blind crossover trial: oral NAC at about 20 mg/kg/day weakened skeletal muscle NF-κB phosphorylation after strenuous eccentric exercise

Direct free radical trapping and chemical quenching

★☆☆☆☆Mechanism evidence: grade DSecondary target

NAC’s free thiol group can react directly with oxidants such as hypochlorous acid in vitro, but it scavenges superoxide anion relatively slowly. Because of the concentrations reached after usual oral doses and competition with endogenous antioxidant systems, direct free-radical scavenging contributes little in the body.

References (2)
  1. Aruoma et al. 1989 · Cell-free reaction kinetics study: NAC reacts directly with some oxidants, but reaction rates differ widely
  2. Overall assessment · Human evidence: no reliable quantitative evidence on how much direct free-radical trapping actually contributes in humans after usual oral doses

Safety and drug interactions

Use with caution in active peptic ulcer disease, because NAC’s mucolytic action may irritate the stomach lining. Gastrointestinal upset is not limited to a few people; some people get mild discomfort after taking it. NAC can enhance the vasodilating effect of nitroglycerin, causing low blood pressure and severe headache, so the two should only be combined under a doctor’s direction.

With PDE5 inhibitors / nitrates High risk

Sildenafil, tadalafil, nitroglycerin, isosorbide mononitrate

Applies only to nitrates such as nitroglycerin: NAC enhances their vasodilating effect, which can cause low blood pressure and severe headache.

Open in the interactive app ›